Toxicities
| Dose level 1* | Dose level 2† | Dose level 3‡ | ||||
| Toxicity grade | 3 | 4 | 3 | 4 | 3 | 4 |
| Neutropenia | 0 | 0 | 0 | 1 | 0 | 2 |
| Anemia | 0 | 0 | 0 | 0 | 0 | 0 |
| Constitutional symptoms | 0 | 0 | 0 | 0 | 1 | 0 |
| Pain | 0 | 0 | 0 | 0 | 0 | 2 |
| Neuropathy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hypophosphatemia | 0 | 0 | 0 | 0 | 1 | 0 |
| Hyponatremia | 0 | 0 | 0 | 0 | 0 | 1 |
| Renal/genito-urinary | 0 | 0 | 0 | 0 | 1 | 0 |
| Infection | 0 | 0 | 0 | 0 | 0 | 1 |
| Gastrointestinal | 0 | 0 | 0 | 0 | 3 | 0 |
| Dermatology | 0 | 0 | 0 | 0 | 1 | 0 |
| Vascular | 0 | 0 | 0 | 0 | 1 | 0 |
*Oxaliplatin 75 mg/m2 IV and docetaxel 50 mg/m2 IP.
†Oxaliplatin 75 mg/m2 IV and docetaxel 75 mg/m2 IP.
‡Oxaliplatin 75 mg/m2 IV and docetaxel 100 mg/m2 IP.
IP, intraperitoneal; IV, intravenous.